Literature DB >> 15694196

Monoamine oxidases A and B gene polymorphisms in migraine patients.

Vedrana Filic1, Anton Vladic, Jasminka Stefulj, Lipa Cicin-Sain, Melita Balija, Zvonimir Sucic, Branimir Jernej.   

Abstract

Abnormal cortical activity and brainstem functioning are considered the possible etiopathogenetic factors of migraine. Monoamine oxidase A and B (MAO-A and -B) regulate the levels of monoamine neurotransmitters, so changes in their activity could participate in migraine pathogenesis. We have investigated the possible association of MAO-A and -B alleles and haplotypes with two common types of migraine, i.e. migraine without aura (MO) and migraine with aura (MA), on the sample of 110 migraineours (80 MO and 30 MA) and 150 controls. MAO-A promoter and MAO-B intron 13 polymorphisms were genotyped by the PCR-based methods. In addition, we have reevaluated the reported association between MAO-B intron 13 polymorphism and platelet MAO-B activity. The platelet MAO-B activity was determined fluorimetrically using kynuramine as a substrate. We have found a tendency toward association of the shorter variant of MAO-A gene promoter with migraine without aura in male subjects. Regarding investigated MAO-B polymorphism, no association with migraine or with platelet MAO-B activity was found. The suggestive association of the variant in MAO-A gene with migraine is considered worthy of independent replication. On the other hand, further studies on MAO-B polymorphism in migraine do not seem promising.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15694196     DOI: 10.1016/j.jns.2004.11.045

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine.

Authors:  Giovanna Gentile; Serena Missori; Marina Borro; Alisa Sebastianelli; Maurizio Simmaco; Paolo Martelletti
Journal:  J Headache Pain       Date:  2010-03-06       Impact factor: 7.277

Review 2.  Kynurenines and headache.

Authors:  Arpád Párdutz; Annamária Fejes; Zsuzsanna Bohár; Lilla Tar; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-06-04       Impact factor: 3.575

3.  MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders.

Authors:  Flora Tassone; Lihong Qi; Wenting Zhang; Robin L Hansen; Isaac N Pessah; Irva Hertz-Picciotto
Journal:  Autism Res       Date:  2011-04-29       Impact factor: 5.216

4.  Association study of monoamine oxidase A/B genes and schizophrenia in Han Chinese.

Authors:  Yi-Liang Wei; Cai-Xia Li; Sheng-Bin Li; Yao Liu; Lan Hu
Journal:  Behav Brain Funct       Date:  2011-10-06       Impact factor: 3.759

5.  Statistical distribution of blood serotonin as a predictor of early autistic brain abnormalities.

Authors:  Skirmantas Janusonis
Journal:  Theor Biol Med Model       Date:  2005-07-19       Impact factor: 2.432

6.  Genetic variants of neurotransmitter-related genes and miRNAs in Egyptian autistic patients.

Authors:  Ahmed M Salem; Samira Ismail; Waheba A Zarouk; Olwya Abdul Baky; Ahmed A Sayed; Sawsan Abd El-Hamid; Sohair Salem
Journal:  ScientificWorldJournal       Date:  2013-12-23

7.  Computational Functional Genomics-Based AmpliSeq™ Panel for Next-Generation Sequencing of Key Genes of Pain.

Authors:  Dario Kringel; Sebastian Malkusch; Eija Kalso; Jörn Lötsch
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

8.  Genetic Contribution of Catechol-O-methyltransferase Polymorphism in Patients with Migraine without Aura.

Authors:  Jeong Wook Park; Kwang Soo Lee; Joong Seok Kim; Yeong In Kim; Hae Eun Shin
Journal:  J Clin Neurol       Date:  2007-03-20       Impact factor: 3.077

9.  Association Between Polymorphisms of DRD2, COMT, DBH, and MAO-A Genes and Migraine Susceptibility: A Meta-Analysis.

Authors:  Hu Chen; Chun-Xue Ji; Lian-Li Zhao; Xiang-Jun Kong; Xian-Tao Zeng
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.